MDLN

Medline Inc. Class A Common Stock
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$46.93B
P/E Ratio
44.72
EPS
$0.78
Beta
52W High
$50.88
52W Low
$32.81
50-Day MA
$38.08
200-Day MA
$41.58
Dividend Yield
Profit Margin
2.32%
Forward P/E
23.42
PEG Ratio

About Medline Inc. Class A Common Stock

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$29.94B
Gross Profit (TTM)$7.84B
EBITDA$2.85B
Operating Margin5.14%
Return on Equity4.94%
Return on Assets3.01%
Revenue/Share (TTM)$34.14
Book Value$13.20
Price-to-Book2.71
Price-to-Sales (TTM)1.57
EV/Revenue1.38
EV/EBITDA15.03
Quarterly Earnings Growth (YoY)262.00%
Quarterly Revenue Growth (YoY)11.60%
Shares Outstanding$877.35M
Float$339.40M
% Insiders0.26%
% Institutions115.97%

Historical Volatility

HV 10-Day
85.00%
HV 20-Day
66.73%
HV 30-Day
61.45%
HV 60-Day
54.76%
HV Rank

Volatility is currently expanding

Analyst Ratings

Consensus ($44.62 target)
7
Strong Buy
16
Buy
4
Hold

Latest News

Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Newsfile Corp8/17/2026Neutral
Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

GlobeNewsWire8/17/2026Neutral
Kaplan Fox Reminds Medline Inc. (MDLN) Investors of an Investigation into Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Newsfile Corp8/14/2026Neutral
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses.

GlobeNewsWire8/12/2026Neutral
Kaplan Fox is Investigating Medline Inc. (MDLN) on Behalf of Investors for Potential Securities Law Violations

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Newsfile Corp8/12/2026Neutral
Kaplan Fox is Investigating Medline Inc. (MDLN) and Encourages Investors Who Suffered Losses to Contact the Firm

New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Newsfile Corp8/10/2026Neutral
Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Newsfile Corp8/7/2026Neutral
NASDAQ: MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Medline Inc. (NASDAQ: MDLN) on behalf of investors who purchased or acquired Medline Inc. Class A common stock and experienced significant financial losses. Medline Reveals Significant FDA Violations On June 2, 2026, the FDA published a warning letter dated May 28, 2026 addressed to Me.

Business Wire8/6/2026Neutral
Allspring Growth Fund Q2 2026 Performance Update

Allspring Growth Fund outperformed the Russell 3000 Growth Index during the quarter. Sandisk Corp. is riding the AI storage super-cycle. Shares of Cencora could not distribute in a 'risk-on' market.

Seeking Alpha8/6/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MDLN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026